| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2008 | EP1904037A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 04/02/2008 | EP1904033A2 Method for producing pharmaceutical compositions containing glimepiride |
| 04/02/2008 | EP1904032A1 Fentanyl formulation containing an essential oil |
| 04/02/2008 | EP1904029A2 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 04/02/2008 | EP1904028A1 Estrogen compositions for vaginal administration |
| 04/02/2008 | EP1903896A1 Process for preparing uronic acid oligosaccharides by extrusion |
| 04/02/2008 | EP1903866A1 Improved delivery of tetrahydrocannabinol |
| 04/02/2008 | EP1851195A4 Process for preparation of probucol derivatives |
| 04/02/2008 | EP1811987B1 Dry powder comprising levothyroxine sodium administered via inhalator |
| 04/02/2008 | EP1802581B1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 04/02/2008 | EP1793817A4 Methods of treating a disorder |
| 04/02/2008 | EP1753427B1 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| 04/02/2008 | EP1729759A4 Salvinorin derivatives and uses thereof |
| 04/02/2008 | EP1711634A4 Naphthalimide dosing by n-acetyl transferase genotyping |
| 04/02/2008 | EP1697384B1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 04/02/2008 | EP1638556B1 2-aminobenzothiazoles as cb1 receptor inverse agonists |
| 04/02/2008 | EP1599445B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 04/02/2008 | EP1592700B1 Avermectin- and avermectin monosaccharide derivatives substituted in the 4''- or 4'- position having pesticidal properties |
| 04/02/2008 | EP1558226A4 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 04/02/2008 | EP1539155B1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 04/02/2008 | EP1476472B1 Novel methylated cyclodextrin complexes |
| 04/02/2008 | EP1476019B1 Aqueous antiseptic based on bispyridiniumalkanes |
| 04/02/2008 | EP1453506B1 Topoisomerase poison agents |
| 04/02/2008 | EP1446160B1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification |
| 04/02/2008 | EP1424898A4 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 04/02/2008 | EP1424889A4 Method for treating lung cancers |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1392331B1 Use of colesevelam or sevelamer hydrogen chloride for lowering serum glucose |
| 04/02/2008 | EP1390027B1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 04/02/2008 | EP1379530A4 Process for the selective preparation of 3-(z) propenyl-cephem compound |
| 04/02/2008 | EP1311260B1 Lipase inhibitors to treat dyspepsia |
| 04/02/2008 | EP1265610A4 Method for reducing or eliminating smoking |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
| 04/02/2008 | EP1129088B1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 04/02/2008 | EP0951282B1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists |
| 04/02/2008 | CN101155923A Method for producing probiotically derived compounds |
| 04/02/2008 | CN101155918A Rnai-mediated inhibition of ocular hypertension targets |
| 04/02/2008 | CN101155823A Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 04/02/2008 | CN101155818A Substituted propane phosphinic acid esters |
| 04/02/2008 | CN101155817A 二氢咪唑并噻唑衍生物 Dihydro-imidazole and thiazole derivatives |
| 04/02/2008 | CN101155816A (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as HIV viral repliation inhibitors |
| 04/02/2008 | CN101155814A Crystals of morphinan derivative and process for producing the same |
| 04/02/2008 | CN101155813A 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/02/2008 | CN101155812A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155811A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155810A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155808A Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 04/02/2008 | CN101155807A Compounds having tie2 (tek) inhibitory activity |
| 04/02/2008 | CN101155806A Oxindole oxazolidinone as antibacterial agent |
| 04/02/2008 | CN101155805A 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 04/02/2008 | CN101155804A Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/02/2008 | CN101155800A Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/02/2008 | CN101155799A Pyrimidine inhibitors of kinases |
| 04/02/2008 | CN101155797A 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 04/02/2008 | CN101155796A Imidazole derivatives |
| 04/02/2008 | CN101155794A Crystalline form of 1-chloro-4-(ss-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 04/02/2008 | CN101155793A Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 04/02/2008 | CN101155791A Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 04/02/2008 | CN101155790A 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101155788A Crystal of 4(3h)-quinazolinone derivative |
| 04/02/2008 | CN101155787A (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines |
| 04/02/2008 | CN101155786A N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 04/02/2008 | CN101155785A Novel adenosine a3 receptor modulators |
| 04/02/2008 | CN101155784A Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 04/02/2008 | CN101155783A Pyrazoles |
| 04/02/2008 | CN101155782A Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 04/02/2008 | CN101155781A Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 04/02/2008 | CN101155780A Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 04/02/2008 | CN101155775A Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
| 04/02/2008 | CN101155600A Radiotherapy enhancer |
| 04/02/2008 | CN101155599A Prevention of hiv-infection with tmc278 |
| 04/02/2008 | CN101155598A Method of treating or preventing type-2 diabetes |
| 04/02/2008 | CN101155592A Method for the mitigation of symptoms of contact lens related dry eye |
| 04/02/2008 | CN101155591A Glucosamine and derivatives thereof useful as tg inhibitors |
| 04/02/2008 | CN101155590A Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| 04/02/2008 | CN101155589A Composition for reducing the exudation of serum proteins |
| 04/02/2008 | CN101155588A Inhibitors of akt activity |
| 04/02/2008 | CN101155587A Modulators of muscarinic receptors |
| 04/02/2008 | CN101155586A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101155585A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101155584A Methods for administering ixabepilone |
| 04/02/2008 | CN101155583A 有丝分裂驱动蛋白的抑制剂 Mitotic kinesin inhibitors |
| 04/02/2008 | CN101155582A Compositions and methods for treating neoplastic diseases |
| 04/02/2008 | CN101155581A Medicament and treatment for herpes simplex |
| 04/02/2008 | CN101155580A Propofol-containing fat emulsion |
| 04/02/2008 | CN101155579A Method for treating gefitinib resistant cancer |
| 04/02/2008 | CN101155577A Local treatment of neurofibromas |
| 04/02/2008 | CN101155511A Method for decreasing cartilage damage in dogs |
| 04/02/2008 | CN101153284A Gene of sheep type brucella M5 mycopremna ribosomal protein L7, its encoding protein and application |
| 04/02/2008 | CN101153262A Health edible calcium-zinc vinegar |
| 04/02/2008 | CN101153045A Novel cephalosporin compounds |
| 04/02/2008 | CN101153044A Wide-spectrum antibiotic cephalosporin alkene compounds containing sulfhydryl thiazole pyridine onium methyl |
| 04/02/2008 | CN101153043A Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN101153042A Thienopyrimidine compound and use of the same |
| 04/02/2008 | CN101153041A 1,2,3-triazole 1,3-nitrogen heterocyclic, producing method and application of the same |
| 04/02/2008 | CN101153039A 13, 13a- dihydro berberine derivant, pharmaceutical composition and uses of the same |
| 04/02/2008 | CN101153028A Compounds with antimicrobial antiviral activity |